Dermott, 72 and who receives care at the James Paget Hospital in Gorleston, is the first person in the UK and Europe to take part in the Phoenix drug trial.

The trial - which has enrolled more than 500 patients globally - is part of a study which aims to determine the effectiveness of a drug called Tinlarebant in slowing the progression of Geographic Atrophy (GA).

Dermott (left) was recruited by Ben Burton (right) to take part in a trailblazing drug trial at the James Paget. (Image: James Paget........

© Eastern Daily Press